News - Roche

Filter

Current filters:

Roche

Popular Filters

126 to 150 of 379 results

PDL files for arbitration for alleged royalties underpayments by Genentech

11-06-2013

USA-based PDL BioPharma (Nasdaq: PDLI) revealed today (June 11) that it has filed a Notice of Arbitration…

BiotechnologyFinancialGenentechLegalPDL BioPharmaPharmaceuticalRoche

Regulatory briefs: Sanofi's Fluzone; Roche' RoActemra; Takeda's Rienso

10-06-2013

French pharma major Sanofi (Euronext: SAN) today (June 10) announced that the US Food and Drug Administration…

Anti-Arthritics/RheumaticsBiotechnologyPharmaceuticalRegulationRocheSanofiTakeda PharmaceuticalsVaccines

Roche's Avastin extends lives of cervical cancer patients; positive in glioblastoma

03-06-2013

Data presented from the study, known as GOG240, showed that the addition of Swiss pharma major Roche's…

AvastinBiotechnologyGenentechOncologyPharmaceuticalResearchRoche

Proposal to list Roche's Neulastim and Actemra in New Zealand

24-05-2013

New Zealand's Pharmaceutical Management Agency PHARMAC has announce the approval of a proposal to list…

ActemraAnti-Arthritics/RheumaticsAsia-PacificNeulastimOncologyPharmaceuticalPricingRegulationRoche

FDA allows marketing of first A1c test labeled for diagnosing diabetes, from Roche

24-05-2013

The US Food and Drug Administration yesterday (May 23) announced that it is allowing marketing of the…

Cobas Integra 800DiabetesPharmaceuticalRegulationRoche

NICE rejects Avastin for ovarian cancer, but backs Lucentis for RVO

22-05-2013

The UK's drugs watchdog the National Institute for Health and Care Excellence (NICE) has this morning…

AvastinBiotechnologyEuropeLucentisNovartisOncologyOphthalmicsPharmaceuticalPricingRegulationRoche

Strong initial data on Genentech's obinutuzumab in most common blood cancer

16-05-2013

Genentech, the biotech subsidiary of Swiss drug major Roche Group (ROG: SIX), has announced positive…

BiotechnologyGA101GenentechobinutuzumabOncologyResearchRoche

US FDA approves companion diagnostic for Tarceva, and new indication for the Roche drug

15-05-2013

The US Food and Drug Administration late yesterday (May 14) approved Swiss drug major Roche (ROG: SIX)…

Boehringer IngelheimNorth AmericaOncologyPharmaceuticalQiagenRegulationRocheTarcevaTomtovok

Study confirms everolimus can overcome trastuzumab resistance in HER-2 positive early breast cancer

03-05-2013

A study that aimed to understand how the cancer drug everolimus helps overcome the resistance breast…

AfinitoreverolimusHerceptinNovartisOncologyPharmaceuticalResearchRochetrastuzumab

Roche restructures Applied Sciences business

23-04-2013

Swiss drug major Roche (ROG: SIX) has announced changes to the Applied Sciences business structure and…

ManagementPharmaceuticalResearchRoche

Roche teams up with Ascletis on hep C treatments for China

15-04-2013

Roche (ROG: SIX) has entered a collaboration with Ascletis Pharmaceuticals, a USA- and China-based biotech…

Anti-viralsAscletis PharmaceuticalsAsia-PacificBiotechnologydanoprevirLicensingMarkets & MarketingPharmaceuticalResearchRoche

New Zealand considers listing of Neulastim and Actemra

12-04-2013

New Zealand's Pharmaceutical Management Agency, PHARMAC, is seeking feedback on a proposal to list pegfilgrastim…

ActemraAnti-Arthritics/RheumaticsAsia-PacificBiotechnologyNeulastimOncologyPharmaceuticalPricingRegulationRoche

Roche 1st-qtr 2013 sales grow 6%, driven by cancer drugs

11-04-2013

Swiss drug major Roche (ROG: SIX) this morning posted first-quarter 2013 sales figures, showing 6% (constant…

BiotechnologyFinancialPharmaceuticalRoche

Roche and Isis Pharma in up to $392 million deal on Huntington's research

09-04-2013

Swiss drug major Roche (ROG: SIX) and USA-based Isis Pharmaceuticals (Nasdaq: ISIS) have formed an alliance…

Isis PharmaceuticalsLicensingMarkets & MarketingPharmaceuticalRare diseasesResearchRoche

UK's NICE draft guidance says "no" to Roche's Avastin for ovarian cancer

25-03-2013

New, draft guidance issued today (March 25) by the UK's drugs watchdog the National Institute for Health…

AvastinOncologyPharmaceuticalPricingRegulationRoche

Russia's Biocad plans to produce high-tech drugs in Brazil

19-03-2013

Biocad, one of Russia's leading biotechnology companies, plans to launch production of several of its…

AvastinBiocadBiotechnologyGenericsHerceptinMabTheraOncologyProductionRocheSouth America

Roche's Pegasys gets EU backing for chronic hepatitis C in children aged five years and older

18-03-2013

The European Medicines Agency has expanded the approval of Swiss drug major Roche's (ROG: SIX) Pegasys…

Anti-viralsBiotechnologyEuropePegasysRegulationRoche

Roche's RoActemra shows superiority to Humira in rheumatoid arthritis

18-03-2013

Over 50% of rheumatoid arthritis patients can achieve low disease activity or remission with Swiss drug…

Anti-Arthritics/RheumaticsBiotechnologyHumiraPharmaceuticalResearchRoActemraRoche

HER2-positive breast cancer patients prefer faster subcutaneous administration of Herceptin to IV

15-03-2013

Results from the PrefHer (Patient Preference for Subcutaneous (SC) versus Intravenous (IV) Herceptin)…

EuropeFinancialHealthcareHerceptinOncologyPharmaceuticalRegulationRoche

Roche pulls out of fibrosis alliance with Galapagos

11-03-2013

Belgium-based Galapagos (Euronext Brussels: GLPG) revealed that Swiss drug major Roche (ROG: SIX) has…

GalapagosLicensingPharmaceuticalRespiratory and PulmonaryRoche

126 to 150 of 379 results

Back to top